ArticleOPEN ACCESS

Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients with Immediate Reactions to the First Dose

JAMA Internal Medicine
DOI: 10.1001/jamainternmed.2021.3779
87Citations
Citations of this article
87Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Krantz, M. S., Kwah, J. H., Stone, C. A., Phillips, E. J., Ortega, G., Banerji, A., & Blumenthal, K. G. (2021, November 1). Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients with Immediate Reactions to the First Dose. JAMA Internal Medicine. American Medical Association. https://doi.org/10.1001/jamainternmed.2021.3779

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free